|
Our
Story
TSE: the disease group
The History of TSE (Prion Diseases)
Sporadic CJD
Familial CJD
Environmental CJD
vCJD
Diagnosing CJD
Therapy
Caring for a loved one with CJD
End of Life Issues
Getting tested for the CJD Mutation
Current Research
Donations
Email
|
Table
1. Pharmacological compounds used in early treatment studies of
experimentally-infected animals.
Compounds
listed in boldface type prolonged incubation periods of infected animals.
|
Anti-virals
Amantidine
Adenine
arabinoside
Cytosine
arabinoside
Isoprinosine
Methisazone
Phosphonoacetic
acid
Rifampicin
Sodium
butyrate
Sodium
thiocyanate
Thiamphenicol
Virazole
Anti-fungals
Amphotericin B
MS-8209
Griseofulvin
Sinefungin
Anti-protozoals
Chloroquin
Glycobiarsol
Metronidazole
Anti-helminthic
Niclosamide
Anti-bacterials
Rifampicin
Sulfamethoxizole
Tetracylcline
Trimethoprin
Thiamphenicol
Polyanions
Carrageenan
Chondroitin
sulfate
Dextran sulfate
Heparan
sulfate
HPA-23
Pentosan polysulfate
Polyvinyl
sulfate
Silicotungstate
|
Lymphoreticular
blockers
Silica
Trypan blue
Interferon
and interferon inducers
Newcastle
disease virus
PolyI:Poly C
Sendai virus
Statolon
Tilorone
HCl
Immunostimulants
Bacterial polysaccharide
BCG
Phytohemagglutinin
Vaccinial
virus
Immunosuppressants
Antilymphocytic serum
Arachis
oil
Steroids
Antineoplastics
Actinomycin D
Cyclophosphamide
Methotrexate
Streptozotocin
Hormones
Adrenalin
Estradiol
Insulin
Prednisone
Propylthiouracil
Testosterone
Miscellaneous
Colchicine
Chlorpromazine
DEAE-dextran
Neutral dextran
Ouabain
Vitamin
C
|
Back
To Top Back To Front Page
|
